Your browser doesn't support javascript.
loading
Factors associated with treatment response to CD19 CAR-T therapy among a large cohort of B cell acute lymphoblastic leukemia.
Zhang, Xian; Yang, Junfang; Li, Jingjing; Li, Wenqian; Song, Dan; Lu, Xin-An; Wu, Fei; Li, Jianqiang; Chen, Dandan; Li, Xiangqun; Xu, Zhongwei; Liu, Shuqiang; Li, Ziyu; Ying, Kui; Lu, Peihua.
Afiliación
  • Zhang X; Hebei Yanda Lu Daopei Hospital, Langfang, China.
  • Yang J; Beijing Lu Daopei Institute of Hematology, No. 22 Tongji South Rd, Yizhuang Economic and Technological Development Zone, Daxing District, Beijing, 100176, China.
  • Li J; Hebei Yanda Lu Daopei Hospital, Langfang, China.
  • Li W; Beijing Lu Daopei Institute of Hematology, No. 22 Tongji South Rd, Yizhuang Economic and Technological Development Zone, Daxing District, Beijing, 100176, China.
  • Song D; Hebei Yanda Lu Daopei Hospital, Langfang, China.
  • Lu XA; Beijing Lu Daopei Institute of Hematology, No. 22 Tongji South Rd, Yizhuang Economic and Technological Development Zone, Daxing District, Beijing, 100176, China.
  • Wu F; Hebei Yanda Lu Daopei Hospital, Langfang, China.
  • Li J; Hebei Yanda Lu Daopei Hospital, Langfang, China.
  • Chen D; Immunochina Pharmaceuticals Co., Ltd., Beijing, China.
  • Li X; Immunochina Pharmaceuticals Co., Ltd., Beijing, China.
  • Xu Z; Hebei Senlang Biotechnology, Shijiazhuang, China.
  • Liu S; Hebei Senlang Biotechnology, Shijiazhuang, China.
  • Li Z; Beijing Doing Biomedical Co., Ltd., Beijing, China.
  • Ying K; Bioceltech Therapeutics Co., Ltd., Beijing, China.
  • Lu P; Tianjin Mycure Medical Technology Co., Ltd., Tianjin, China.
Cancer Immunol Immunother ; 71(3): 689-703, 2022 Mar.
Article en En | MEDLINE | ID: mdl-34365516

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras B / Inmunoterapia Adoptiva / Antígenos CD19 / Receptores Quiméricos de Antígenos Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Idioma: En Revista: Cancer Immunol Immunother Asunto de la revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras B / Inmunoterapia Adoptiva / Antígenos CD19 / Receptores Quiméricos de Antígenos Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Idioma: En Revista: Cancer Immunol Immunother Asunto de la revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: China